Hims & Hers Health, Inc. (HIMS)
Listed on NYSE • Consumer Defensive / Household & Personal Products
Overview
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Explore More Data
Key Information
Symbol:
HIMS
CEO:
Andrew Dudum
Exchange:
NYSE
CIK:
0001773751
Website:
https://www.forhims.com
SEC Filings:
View SEC →
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Price
43.73
Change
0.94
Change %
2.20%
Open
44.1
Previous Close
42.79
High
46.82
Low
43.7
Volume
36,095,556
Market Cap
9,955,068,928
EV/EBITDA
64
Capital Structure (Updated: Nov 05 04:00 PM EST)
Shares Outstanding
219,270,891
FloatShares
205,737,345
Float Ratio
93.83%
Shares Short
66,883,420
Short Percent Of Float
The percent of float shares currently sold short. Reflects market sentiment and risk of a short squeeze.
36.67%
Short Ratio
Days needed to cover all short positions. Indicates short-selling pressure.
2.3 trading days
Held Percent Insiders
6.29%
Held Percent Institutions
81.42%
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-11-03 |
| Earnings Call | 2025-11-03 |
| Avg EPS Estimate | 0.1878 |
| Low EPS Estimate | 0.13 |
| High EPS Estimate | 0.25 |
| Revenue | |
| Avg Revenue Forecast | 617,496,010 |
| Low Revenue Forecast | 608,224,000 |
| High Revenue Forecast | 624,716,660 |
HIMS Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $629,744,000 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 1.489 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 1.875 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $1,118,023,040 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
HIMS Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $168,504,000 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $325,079,008 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $195,340,624 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 75.01% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 2.06% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | 6.05% | Net profit margin, which reflects overall profitability. |
HIMS Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 192.44% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $1,118,023,040 | Used together with cash and EBITDA to assess debt-paying ability. |
HIMS Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | 49.20% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | -80.30% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for HIMS (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $43.73 | Latest stock trading price |
| Price Target (High) | $85 | Analyst highest expected price |
| Price Target (Low) | $25 | Analyst lowest expected price |
| Price Target (Average) | $47.08 | Average target price across analysts |
| Price Target (Median) | $46 | Median of target prices |
| Average Rating Score | 2.93 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | hold | Consensus rating |
| Analyst Coverage Count | 13 | Number of analysts providing estimates |
| Cash Holdings | $629,744,000 | Total cash held by the company |
| Cash per Share | $2.77 | Cash value per outstanding share |
| Total Debt | $1,118,023,040 | Company's total debt |
| Quick Ratio | 1.489 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 1.875 | Overall short-term liquidity |
| Debt/Equity Ratio | 192.44% | Leverage ratio: Debt / Equity |
| EBITDA | $168,504,000 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $2,210,958,080 | Total company revenue |
| Revenue per Share | $9.917 | Total revenue divided by shares outstanding |
| Gross Profit | 75.01% | Revenue minus cost of goods sold |
| Return on Assets | 5.56% | Net income / Total assets |
| Return on Equity | 26.21% | Net income / Shareholder equity |
| Earnings Growth (YoY) | -80.30% | Year-over-year EPS growth |
| Revenue Growth (YoY) | 49.20% | Year-over-year revenue growth |
| Gross Margin | 75.01% | Gross profit / Total revenue |
| EBITDA Margin | 7.62% | EBITDA / Revenue |
| Operating Margin | 2.06% | Operating income / Revenue |
| Profit Margin | 6.05% | Net income / Revenue |
| Free Cash Flow | $195,340,624 | Cash left after capital expenditures |
| Operating Cash Flow | $325,079,008 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |